Berghmans, E.; Jacobs, J.; Deben, C.; Hermans, C.; Broeckx, G.; Smits, E.; Maes, E.; Raskin, J.; Pauwels, P.; Baggerman, G.
Mass Spectrometry Imaging Reveals Neutrophil Defensins as Additional Biomarkers for Anti-PD-(L)1 Immunotherapy Response in NSCLC Patients. Cancers 2020, 12, 863.
https://doi.org/10.3390/cancers12040863
AMA Style
Berghmans E, Jacobs J, Deben C, Hermans C, Broeckx G, Smits E, Maes E, Raskin J, Pauwels P, Baggerman G.
Mass Spectrometry Imaging Reveals Neutrophil Defensins as Additional Biomarkers for Anti-PD-(L)1 Immunotherapy Response in NSCLC Patients. Cancers. 2020; 12(4):863.
https://doi.org/10.3390/cancers12040863
Chicago/Turabian Style
Berghmans, Eline, Julie Jacobs, Christophe Deben, Christophe Hermans, Glenn Broeckx, Evelien Smits, Evelyne Maes, Jo Raskin, Patrick Pauwels, and Geert Baggerman.
2020. "Mass Spectrometry Imaging Reveals Neutrophil Defensins as Additional Biomarkers for Anti-PD-(L)1 Immunotherapy Response in NSCLC Patients" Cancers 12, no. 4: 863.
https://doi.org/10.3390/cancers12040863
APA Style
Berghmans, E., Jacobs, J., Deben, C., Hermans, C., Broeckx, G., Smits, E., Maes, E., Raskin, J., Pauwels, P., & Baggerman, G.
(2020). Mass Spectrometry Imaging Reveals Neutrophil Defensins as Additional Biomarkers for Anti-PD-(L)1 Immunotherapy Response in NSCLC Patients. Cancers, 12(4), 863.
https://doi.org/10.3390/cancers12040863
